POST Online Media Lite Edition


Russia's Sputnik V jumps ahead of American Pfizer to be second most approved COVID-19 vaccine

Christian Fernsby |
Russia's Sputnik V COVID-19 vaccine has been ranked as the world's second vaccine in terms of regulatory approvals, surpassing the American-made Pfizer jab.

Article continues below

Topics: RUSSIA   

"SputnikV is now the world's second most popular CovidVaccine in terms of regulatory approvals," the Russian Direct Investment Fund (RDIF) tweeted.

According to the ranking, the AstraZeneca vaccine billed as AZD1222 topped the list of the most-approved Covid-19 vaccines in the world as it is registered in 49 countries.

Co-invented by Oxford University and AstraZeneca, the AZD1222 vaccine, which was approved by European regulators but not by the Americans, showed 62% efficacy in preventing Covid-19 infections in its clinical trials. AstraZeneca joined hands with the Serum Institute of India to manufacture and ship the vaccine across the globe.

The prestigious Lancet medical journal published in early February the latest stage results that showed an impressive 92% efficacy for the vaccine. According to the results, Sputnik V is claimed to be safe and offers complete protection against hospitalization and death.

What to read next

Canada to receive 2m doses of AstraZeneca’s vaccine manufactured by Serum Institute of India
Canada to receive early delivery of Pfizer BioNTech coronavirus vaccine
Australia, New Zealand receive first vaccine shipments